Investors
To invest in Neola Medical
At Neola Medical, our vision is to save more preterm born babies worldwide and prevent costly complications that can lead to severe disabilities later in life. Through our groundbreaking medical device, Neola®, we aim to transform neonatal intensive care by offering non-invasive, continuous, real-time lung monitoring. This technology enables the immediate detection of life-threatening complications, supporting proactive care, reducing morbidity, and improving the quality of life for these vulnerable patients.
Neola® is specifically designed to address the critical needs of preterm born babies, positioning Neola Medical as a leader in a growing and non-cyclical pediatric medical device market. By utilizing patented GASMAS technology, Neola® continuously measures lung volume changes and oxygen gas concentration, allowing healthcare professionals to instantly detect complications such as airway obstructions or lung collapse — well before they become apparent through current methods.
Neola®, has been recognised by leading experts in neonatology at Stanford University as a promising innovation with the potential to upgrade neonatal intensive care from the first day in the clinic. As a result, Neola Medical is one of the few companies that have been selected as a Stanford Impact1 company to receive support from the Stanford Impact1 program. The program is supported and partly financed by the US Food and Drug Administration (FDA), with the aim of supporting advanced technological innovation designed for children to reach the market and the vulnerable pediatric patient group as quickly as possible.
As we approach the commercial launch of Neola®, we are focused on obtaining market approval in the U.S. followed by Europe. Supported by a strong tradition of Swedish medical technology innovation, Neola® has the potential to set a new standard of care, saving lives and significantly improving outcomes for preterm born babies worldwide.
Information about risks and uncertainties at our website here.
“At Neola Medical, our mission is to provide preterm born babies with a stronger and safer start in life. By offering non-invasive, continuous, real-time lung monitoring with our groundbreaking medical technology, Neola®, we aim to detect complications immediately, giving healthcare professionals the tools they need to make life-saving decisions. We are proud to be at the forefront of a new era in neonatal care, where every breath counts, and every life has the chance to thrive.”
– CEO Hanna Sjöström